비교리스트

 카트 문의
시장보고서
상품코드
1424031

단순포진바이러스 치료 시장 점유율, 규모, 동향, 산업 분석 보고서 : 유형별, 약물별, 백신별, 투여 경로별, 최종 용도별, 지역별, 부문별 예측(2024-2032년)

Herpes Simplex Virus Treatment Market Share, Size, Trends, Industry Analysis Report, By Type (Herpes Simplex Virus-1, Herpes simplex virus-2); By Drug; By Vaccine; By Route of Administration; By End-use; By Region; Segment Forecast, 2024 - 2032
발행일: | 리서치사: Polaris Market Research | 페이지 정보: 영문 115 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

Polaris Market Research의 최신 조사에 따르면, 세계 단순포진바이러스 치료 시장 규모는 2032년까지 46억 6,000만 달러에 달할 것으로 예상됩니다. 이 보고서는 현재 시장 역학에 대한 자세한 인사이트와 향후 시장 성장에 대한 분석을 제공합니다.

바이러스의 전염성이 높기 때문에 정부 기관과 사람들은 가능한 한 빨리 치료를 받아야 합니다. 단순포진은 인체 감염률에 따라 두 가지 유형으로 나뉘는데, HSV-1은 보통 감염자의 피부 접촉을 통해 감염됩니다. 반면, HSV-2는 입술 헤르페스이며, 주로 소아기에 감염된 사람의 타액과 성행위 이외의 접촉을 통해 감염됩니다. 단순포진바이러스의 효율적인 치료가 필요한 큰 이유 중 하나는 한 번 감염되면 평생 지속될 수 있다는 점입니다.

단순포진바이러스는 인체에 들어가면 잠복 네트워크를 형성하고, 1주일에서 10일 정도면 사라지지만 코와 입 주변 피부에 통증을 동반한 물집이 생길 수 있습니다. 경우에 따라 단순포진은 유해한 뇌염이나 안구 감염을 유발할 수도 있습니다. 세계보건기구(WHO)에 따르면, 단순포진바이러스는 전 세계 인구의 약 2/3가 앓고 있을 정도로 사회적으로 흔한 질병입니다. 이는 세계 시장에서 단순포진바이러스 치료의 본질을 강조하고 있습니다.

단순포진바이러스 치료를 위한 새로운 치료법을 혁신하기 위한 연구 개발 활동이 증가함에 따라 시장에 큰 성장 기회가 있을 것으로 예상됩니다. 예를 들어, Nature Communications에 게재된 2023년 연구는 세포 환경과 단순포진바이러스 유형 1의 관계를 탐구하여 두 가지가 서로 연관되어 있음을 밝혔습니다. 이러한 연구는 예측 기간 동안 단순포진바이러스 치료의 발전을 촉진할 것으로 예상됩니다.

또한, 단순포진바이러스 치료를 위한 혁신적인 백신에 대한 투자가 증가하면서 시장 성장을 크게 촉진하고 있습니다. 예를 들어, Shenzhen Mellow Hope Pharm Industrial과 Rational Vaccines는 중국에서 헤르페스 백신을 개발하기 위해 전략적 제휴를 맺었습니다.

단순포진바이러스 치료 시장 보고서 하이라이트

단순포진바이러스-1(HSV-1) 부문은 높은 감염률로 인해 향후 몇 년 동안 가장 높은 성장세를 보일 것으로 예상됩니다.

발라시클로버 부문은 치료제의 높은 흡수율로 인해 가장 큰 시장 점유율을 차지하고 있습니다.

아시아태평양은 감염자와의 접촉 위험으로 인해 예측 기간 동안 가장 빠른 성장을 기록할 것으로 예상됩니다.

목차

서론

  • 보고서 설명
    • 연구 목적
    • 시장 범위
    • 가정
  • 이해관계자

제2장 주요 요약

제3장 조사 방법

제4장 세계의 단순포진바이러스 치료 시장 인사이트

  • 단순포진바이러스 치료 - 업계 현황
  • 단순포진바이러스 치료 시장 역학
    • 성장 촉진요인과 기회
      • 세계의 감염률 상승
      • 세포 치료 및 유전자 치료를 탐구하는 연구 증가가 시장 성장을 추진
    • 성장 억제요인과 과제
      • 규제상 허들이 시장 성장을 저해할 가능성이 있다
  • PESTLE 분석
  • 단순포진바이러스 치료 업계 동향
  • COVID-19 감염증의 영향 분석

제5장 세계의 단순포진바이러스 치료 시장, 유형별

  • 주요 조사 결과
  • 서론
  • 단순포진바이러스-1(HSV-1)
  • 단순포진바이러스-2(HSV-2)

제6장 세계의 단순포진바이러스 치료 시장, 약제별

  • 주요 조사 결과
  • 서론
  • 아시클로버
  • 발라시클로버
  • 팜시클로버
  • 기타 약물

제7장 세계의 단순포진바이러스 치료 시장, 백신별

  • 주요 조사 결과
  • 서론
  • 심플리릭스
  • 기타

제8장 세계의 단순포진바이러스 치료 시장, 투여 경로별

  • 주요 조사 결과
  • 서론
  • 경구
  • 주사
  • 국소

제9장 세계의 단순포진바이러스 치료 시장, 최종 용도별

  • 주요 조사 결과
  • 서론
  • 병원 약국
  • 소매 약국
  • 온라인 약국

제10장 세계의 단순포진바이러스 치료 시장, 지역별

  • 주요 조사 결과
  • 서론
    • 단순포진바이러스 치료 시장 평가, 지역별, 2019-2032년
  • 단순포진바이러스 치료 시장 - 북미
    • 북미 : 단순포진바이러스 치료 시장, 유형별, 2019-2032년
    • 북미 : 단순포진바이러스 치료 시장, 투여 경로별, 2019-2032년
    • 북미 : 단순포진바이러스 치료 시장, 약제별, 2019-2032년
    • 북미 : 단순포진바이러스 치료 시장, 백신별, 2019-2032년
    • 북미 : 단순포진바이러스 치료 시장, 최종 용도별, 2019-2032년
    • 단순포진바이러스 치료 시장 - 미국
    • 단순포진바이러스 치료 시장 - 캐나다
  • 단순포진바이러스 치료 시장 - 유럽
    • 유럽 : 단순포진바이러스 치료 시장, 유형별, 2019-2032년
    • 유럽 : 단순포진바이러스 치료 시장, 투여 경로별, 2019-2032년
    • 유럽 : 단순포진바이러스 치료 시장, 약제별, 2019-2032년
    • 유럽 : 단순포진바이러스 치료 시장, 백신별, 2019-2032년
    • 유럽 : 단순포진바이러스 치료 시장, 최종 용도별, 2019-2032년
    • 단순포진바이러스 치료 시장 - 영국
    • 단순포진바이러스 치료 시장 - 프랑스
    • 단순포진바이러스 치료 시장 - 독일
    • 단순포진바이러스 치료 시장 - 이탈리아
    • 단순포진바이러스 치료 시장 - 스페인
    • 단순포진바이러스 치료 시장 - 네덜란드
    • 단순포진바이러스 치료 시장 - 러시아
  • 단순포진바이러스 치료 시장 - 아시아태평양
    • 아시아태평양 : 단순포진바이러스 치료 시장, 유형별, 2019-2032년
    • 아시아태평양 : 단순포진바이러스 치료 시장, 투여 경로별, 2019-2032년
    • 아시아태평양 : 단순포진바이러스 치료 시장, 약제별, 2019-2032년
    • 아시아태평양 : 단순포진바이러스 치료 시장, 백신별, 2019-2032년
    • 아시아태평양 : 단순포진바이러스 치료 시장, 최종 용도별, 2019-2032년
    • 단순포진바이러스 치료 시장 - 중국
    • 단순포진바이러스 치료 시장 - 인도
    • 단순포진바이러스 치료 시장 - 일본
    • 단순포진바이러스 치료 시장 - 말레이시아
    • 단순포진바이러스 치료 시장 - 인도네시아
    • 단순포진바이러스 치료 시장 - 한국
  • 단순포진바이러스 치료 시장 - 중동 및 아프리카
    • 중동 및 아프리카 : 단순포진바이러스 치료 시장, 유형별, 2019-2032년
    • 중동 및 아프리카 : 단순포진바이러스 치료 시장, 투여 경로별, 2019-2032년
    • 중동 및 아프리카 : 단순포진바이러스 치료 시장, 약제별, 2019-2032년
    • 중동 및 아프리카 : 단순포진바이러스 치료 시장, 백신별, 2019-2032년
    • 중동 및 아프리카 : 단순포진바이러스 치료 시장, 최종 용도별, 2019-2032년
    • 단순포진바이러스 치료 시장 - 사우디아라비아
    • 단순포진바이러스 치료 시장 - 아랍에미리트
    • 단순포진바이러스 치료 시장 - 이스라엘
    • 단순포진바이러스 치료 시장 - 남아프리카공화국
  • 단순포진바이러스 치료 시장 - 라틴아메리카
    • 라틴아메리카 : 단순포진바이러스 치료 시장, 유형별, 2019-2032년
    • 라틴아메리카 : 단순포진바이러스 치료 시장, 투여 경로별, 2019-2032년
    • 라틴아메리카 : 단순포진바이러스 치료 시장, 약제별, 2019-2032년
    • 라틴아메리카 : 단순포진바이러스 치료 시장, 백신별, 2019-2032년
    • 라틴아메리카 : 단순포진바이러스 치료 시장, 최종 용도별, 2019-2032년
    • 단순포진바이러스 치료 시장 - 멕시코
    • 단순포진바이러스 치료 시장 - 브라질
    • 단순포진바이러스 치료 시장 - 아르헨티나

제11장 경쟁 상황

  • 확장과 인수 분석
    • 확대
    • 인수
  • 제휴/협업/합의/공개

제12장 기업 개요

  • Apotex Inc.
  • Carlsbad Tech
  • Emcure Pharmaceuticals Ltd.
  • Fresenius Kabi AG
  • GSK plc
  • Glenmark Pharmaceuticals Inc.
  • Novartis AG
  • Sanofi
  • Teva Pharmaceuticals Industries Ltd.
  • Viatris, Inc.
ksm 24.02.23

The global herpes simplex virus treatment market size is expected to reach USD 4.66 billion by 2032, according to a new study by Polaris Market Research. The report "Herpes Simplex Virus Treatment Market Share, Size, Trends, Industry Analysis Report, By Type (Herpes Simplex Virus-1, Herpes simplex virus-2); By Drug; By Vaccine; By Route of Administration; By End-use; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The higher transmission potential of viruses is forcing government agencies and people to get treatment as quickly as possible. Herpes simplex is a virus that is divided into two types based on the infection rate among humans. HSV-1 is usually transmitted through skin-to-skin contact from the infected person. At the same time, HSV-2 is an oral herpes that mostly infects children during childhood due to non-sexual contact with the saliva of infected people. One of the major factors driving the need for efficient treatment of the herpes simplex virus is that if a person gets infected once, then it can last forever.

The herpes simplex virus builds a latent network once it gets inside the human body. While it is likely to vanish after a week to ten days, it can cause painful blisters on the skin around the nose and mouth. In some cases, herpes simplex may lead to harmful brain inflammation and eye infections. According to the World Health Organization, the herpes simplex virus is a more common disease in society, affecting about two-thirds of the world population. This is emphasizing the essence of herpes simplex virus treatment in the global market.

The growing research and development activities to innovate new therapies with the potential to cure herpes simplex virus treatment are expected to showcase significant growth opportunities in the market. For instance, a 2023 study published in Nature Communications explored the relationship between the cellular landscape and herpes simplex virus type 1 and revealed that both are connected. These research studies are expected to drive advancements in herpes simplex virus treatment during the forecast period.

Moreover, rising investments in innovative vaccines for the treatment of the herpes simplex virus are significantly driving market growth. For instance, Shenzhen Mellow Hope Pharm Industrial. & Rational Vaccines entered into a strategic collaboration to develop herpes vaccines in China.

Herpes Simplex Virus Treatment Market Report Highlights

The Herpes Simplex Virus-1 (HSV-1) segment is anticipated to witness the highest growth in the coming years due to the higher rate of transmission.

Valacyclovir segment accounted for the largest market share owing to the potential for a higher absorption rate of treatment.

Asia Pacific is projected to register the fastest growth during the forecast period, attributable to the risk of contact with infected persons.

The global players include Apotex Inc., Carlsbad Tech, Emcure Pharmaceuticals Ltd., Fresenius Kabi AG, GSK plc, Glenmark Pharmaceuticals Inc., & Novartis AG.

Polaris Market Research has segmented the herpes simplex virus treatment market report based on type, drug, vaccine, route of administration, end-use, and region:

Herpes Simplex Virus Treatment, Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Herpes Simplex Virus-1 (HSV-1)
  • Herpes simplex virus-2 (HSV-2)

Herpes Simplex Virus Treatment, Drug Outlook (Revenue - USD Billion, 2019 - 2032)

  • Acyclovir
  • Valacyclovir
  • Famciclovir
  • Other Drugs

Herpes Simplex Virus Treatment, Vaccine Outlook (Revenue - USD Billion, 2019 - 2032)

  • Simplirix
  • Others

Herpes Simplex Virus Treatment, Route of Administration Outlook (Revenue - USD Billion, 2019 - 2032)

  • Oral
  • Injectable
  • Topical

Herpes Simplex Virus Treatment, End-use Outlook (Revenue - USD Billion, 2019 - 2032)

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

Herpes Simplex Virus Treatment, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Herpes Simplex Virus Treatment Market Insights

  • 4.1. Herpes Simplex Virus Treatment - Industry Snapshot
  • 4.2. Herpes Simplex Virus Treatment Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. The rising infection rate in the world
      • 4.2.1.2. The rising studies exploring cell and gene therapies are driving the market growth
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Regulatory hurdles are likely to impede market growth
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Herpes Simplex Virus Treatment Industry Trends
  • 4.6. COVID-19 Impact Analysis

5. Global Herpes Simplex Virus Treatment Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
  • 5.3. Herpes Simplex Virus-1 (HSV-1)
    • 5.3.1. Global Herpes Simplex Virus Treatment Market, by Herpes Simplex Virus-1 (HSV-1), by Region, 2019-2032 (USD Billion)
  • 5.4. Herpes simplex virus-2 (HSV-2)
    • 5.4.1. Global Herpes Simplex Virus Treatment Market, by Herpes simplex virus-2 (HSV-2), by Region, 2019-2032 (USD Billion)

6. Global Herpes Simplex Virus Treatment Market, by Drug

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
  • 6.3. Acyclovir
    • 6.3.1. Global Herpes Simplex Virus Treatment Market, by Acyclovir, by Region, 2019-2032 (USD Billion)
  • 6.4. Valacyclovir
    • 6.4.1. Global Herpes Simplex Virus Treatment Market, by Valacyclovir, by Region, 2019-2032 (USD Billion)
  • 6.5. Famciclovir
    • 6.5.1. Global Herpes Simplex Virus Treatment Market, by Famciclovir, by Region, 2019-2032 (USD Billion)
  • 6.6. Other Drugs
    • 6.6.1. Global Herpes Simplex Virus Treatment Market, by Other Drugs, by Region, 2019-2032 (USD Billion)

7. Global Herpes Simplex Virus Treatment Market, by Vaccine

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
  • 7.3. Simplirix
    • 7.3.1. Global Herpes Simplex Virus Treatment Market, by Simplirix, by Region, 2019-2032 (USD Billion)
  • 7.4. Others
    • 7.4.1. Global Herpes Simplex Virus Treatment Market, by Others, by Region, 2019-2032 (USD Billion)

8. Global Herpes Simplex Virus Treatment Market, by Route of Administration

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
  • 8.3. Oral
    • 8.3.1. Global Herpes Simplex Virus Treatment Market, by Oral, by Region, 2019-2032 (USD Billion)
  • 8.4. Injectable
    • 8.4.1. Global Herpes Simplex Virus Treatment Market, by Injectable, by Region, 2019-2032 (USD Billion)
  • 8.5. Topical
    • 8.5.1. Global Herpes Simplex Virus Treatment Market, by Topical, by Region, 2019-2032 (USD Billion)

9. Global Herpes Simplex Virus Treatment Market, by End Use

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Global Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
  • 9.3. Hospital Pharmacy
    • 9.3.1. Global Herpes Simplex Virus Treatment Market, by Hospital Pharmacy, by Region, 2019-2032 (USD Billion)
  • 9.4. Retail Pharmacy
    • 9.4.1. Global Herpes Simplex Virus Treatment Market, by Retail Pharmacy, by Region, 2019-2032 (USD Billion)
  • 9.5. Online Pharmacy
    • 9.5.1. Global Herpes Simplex Virus Treatment Market, by Online Pharmacy, by Region, 2019-2032 (USD Billion)

10. Global Herpes Simplex Virus Treatment Market, by Geography

  • 10.1. Key findings
  • 10.2. Introduction
    • 10.2.1. Herpes Simplex Virus Treatment Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 10.3. Herpes Simplex Virus Treatment Market - North America
    • 10.3.1. North America: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
    • 10.3.2. North America: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
    • 10.3.3. North America: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
    • 10.3.4. North America: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
    • 10.3.5. North America: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
    • 10.3.6. Herpes Simplex Virus Treatment Market - U.S.
      • 10.3.6.1. U.S.: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
      • 10.3.6.2. U.S.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.3.6.3. U.S.: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
      • 10.3.6.4. U.S.: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
      • 10.3.6.5. U.S.: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
    • 10.3.7. Herpes Simplex Virus Treatment Market - Canada
      • 10.3.7.1. Canada: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
      • 10.3.7.2. Canada.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.3.7.3. Canada: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
      • 10.3.7.4. Canada: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
      • 10.3.7.5. Canada: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
  • 10.4. Herpes Simplex Virus Treatment Market - Europe
    • 10.4.1. Europe: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
    • 10.4.2. Europe.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
    • 10.4.3. Europe: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
    • 10.4.4. Europe: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
    • 10.4.5. Europe: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
    • 10.4.6. Herpes Simplex Virus Treatment Market - UK
      • 10.4.6.1. UK: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
      • 10.4.6.2. UK.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.4.6.3. UK: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
      • 10.4.6.4. UK: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
      • 10.4.6.5. UK: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
    • 10.4.7. Herpes Simplex Virus Treatment Market - France
      • 10.4.7.1. France: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
      • 10.4.7.2. France.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.4.7.3. France: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
      • 10.4.7.4. France: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
      • 10.4.7.5. France: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
    • 10.4.8. Herpes Simplex Virus Treatment Market - Germany
      • 10.4.8.1. Germany: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
      • 10.4.8.2. Germany.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.4.8.3. Germany: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
      • 10.4.8.4. Germany: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
      • 10.4.8.5. Germany: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
    • 10.4.9. Herpes Simplex Virus Treatment Market - Italy
      • 10.4.9.1. Italy: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
      • 10.4.9.2. Italy.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.4.9.3. Italy: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
      • 10.4.9.4. Italy: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
      • 10.4.9.5. Italy: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
    • 10.4.10. Herpes Simplex Virus Treatment Market - Spain
      • 10.4.10.1. Spain: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
      • 10.4.10.2. Spain.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.4.10.3. Spain: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
      • 10.4.10.4. Spain: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
      • 10.4.10.5. Spain: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
    • 10.4.11. Herpes Simplex Virus Treatment Market - Netherlands
      • 10.4.11.1. Netherlands: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
      • 10.4.11.2. Netherlands.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.4.11.3. Netherlands: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
      • 10.4.11.4. Netherlands: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
      • 10.4.11.5. Netherlands: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
    • 10.4.12. Herpes Simplex Virus Treatment Market - Russia
      • 10.4.12.1. Russia: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
      • 10.4.12.2. Russia.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.4.12.3. Russia: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
      • 10.4.12.4. Russia: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
      • 10.4.12.5. Russia: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
  • 10.5. Herpes Simplex Virus Treatment Market - Asia Pacific
    • 10.5.1. Asia Pacific: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
    • 10.5.2. Asia Pacific.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
    • 10.5.3. Asia Pacific: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
    • 10.5.4. Asia Pacific: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
    • 10.5.5. Asia Pacific: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
    • 10.5.6. Herpes Simplex Virus Treatment Market - China
      • 10.5.6.1. China: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
      • 10.5.6.2. China.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.5.6.3. China: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
      • 10.5.6.4. China: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
      • 10.5.6.5. China: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
    • 10.5.7. Herpes Simplex Virus Treatment Market - India
      • 10.5.7.1. India: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
      • 10.5.7.2. India.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.5.7.3. India: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
      • 10.5.7.4. India: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
      • 10.5.7.5. India: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
    • 10.5.8. Herpes Simplex Virus Treatment Market - Japan
      • 10.5.8.1. Japan: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
      • 10.5.8.2. Japan.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.5.8.3. Japan: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
      • 10.5.8.4. Japan: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
      • 10.5.8.5. Japan: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
    • 10.5.9. Herpes Simplex Virus Treatment Market - Malaysia
      • 10.5.9.1. Malaysia: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
      • 10.5.9.2. Malaysia.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.5.9.3. Malaysia: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
      • 10.5.9.4. Malaysia: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
      • 10.5.9.5. Malaysia: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
    • 10.5.10. Herpes Simplex Virus Treatment Market - Indonesia
      • 10.5.10.1. Indonesia: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
      • 10.5.10.2. Indonesia.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.5.10.3. Indonesia: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
      • 10.5.10.4. Indonesia: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
      • 10.5.10.5. Indonesia: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
    • 10.5.11. Herpes Simplex Virus Treatment Market - South Korea
      • 10.5.11.1. South Korea: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
      • 10.5.11.2. South Korea.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.5.11.3. South Korea: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
      • 10.5.11.4. South Korea: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
      • 10.5.11.5. South Korea: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
  • 10.6. Herpes Simplex Virus Treatment Market - Middle East & Africa
    • 10.6.1. Middle East & Africa: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
    • 10.6.2. Middle East & Africa: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
    • 10.6.3. Middle East & Africa: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
    • 10.6.4. Middle East & Africa: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
    • 10.6.5. Middle East & Africa: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
    • 10.6.6. Herpes Simplex Virus Treatment Market - Saudi Arabia
      • 10.6.6.1. Saudi Arabia: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
      • 10.6.6.2. Saudi Arabia.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.6.6.3. Saudi Arabia: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
      • 10.6.6.4. Saudi Arabia: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
      • 10.6.6.5. Saudi Arabia: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
    • 10.6.7. Herpes Simplex Virus Treatment Market - UAE
      • 10.6.7.1. UAE: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
      • 10.6.7.2. UAE.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.6.7.3. UAE: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
      • 10.6.7.4. UAE: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
      • 10.6.7.5. UAE: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
    • 10.6.8. Herpes Simplex Virus Treatment Market - Israel
      • 10.6.8.1. Israel: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
      • 10.6.8.2. Israel.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.6.8.3. Israel: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
      • 10.6.8.4. Israel: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
      • 10.6.8.5. Israel: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
    • 10.6.9. Herpes Simplex Virus Treatment Market - South Africa
      • 10.6.9.1. South Africa: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
      • 10.6.9.2. South Africa.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.6.9.3. South Africa: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
      • 10.6.9.4. South Africa: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
      • 10.6.9.5. South Africa: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
  • 10.7. Herpes Simplex Virus Treatment Market - Latin America
    • 10.7.1. Latin America: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
    • 10.7.2. Latin America.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
    • 10.7.3. Latin America: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
    • 10.7.4. Latin America: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
    • 10.7.5. Latin America: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
    • 10.7.6. Herpes Simplex Virus Treatment Market - Mexico
      • 10.7.6.1. Mexico: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
      • 10.7.6.2. Mexico.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.7.6.3. Mexico: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
      • 10.7.6.4. Mexico: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
      • 10.7.6.5. Mexico: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
    • 10.7.7. Herpes Simplex Virus Treatment Market - Brazil
      • 10.7.7.1. Brazil: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
      • 10.7.7.2. Brazil.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.7.7.3. Brazil: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
      • 10.7.7.4. Brazil: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
      • 10.7.7.5. Brazil: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
    • 10.7.8. Herpes Simplex Virus Treatment Market - Argentina
      • 10.7.8.1. Argentina: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
      • 10.7.8.2. Argentina.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.7.8.3. Argentina: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
      • 10.7.8.4. Argentina: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
      • 10.7.8.5. Argentina: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)

11. Competitive Landscape

  • 11.1. Expansion and Acquisition Analysis
    • 11.1.1. Expansion
    • 11.1.2. Acquisitions
  • 11.2. Partnerships/Collaborations/Agreements/Exhibitions

12. Company Profiles

  • 12.1. Apotex Inc.
    • 12.1.1. Company Overview
    • 12.1.2. Financial Performance
    • 12.1.3. Product Benchmarking
    • 12.1.4. Recent Development
  • 12.2. Carlsbad Tech
    • 12.2.1. Company Overview
    • 12.2.2. Financial Performance
    • 12.2.3. Product Benchmarking
    • 12.2.4. Recent Development
  • 12.3. Emcure Pharmaceuticals Ltd.
    • 12.3.1. Company Overview
    • 12.3.2. Financial Performance
    • 12.3.3. Product Benchmarking
    • 12.3.4. Recent Development
  • 12.4. Fresenius Kabi AG
    • 12.4.1. Company Overview
    • 12.4.2. Financial Performance
    • 12.4.3. Product Benchmarking
    • 12.4.4. Recent Development
  • 12.5. GSK plc
    • 12.5.1. Company Overview
    • 12.5.2. Financial Performance
    • 12.5.3. Product Benchmarking
    • 12.5.4. Recent Development
  • 12.6. Glenmark Pharmaceuticals Inc.
    • 12.6.1. Company Overview
    • 12.6.2. Financial Performance
    • 12.6.3. Product Benchmarking
    • 12.6.4. Recent Development
  • 12.7. Novartis AG
    • 12.7.1. Company Overview
    • 12.7.2. Financial Performance
    • 12.7.3. Product Benchmarking
    • 12.7.4. Recent Development
  • 12.8. Sanofi
    • 12.8.1. Company Overview
    • 12.8.2. Financial Performance
    • 12.8.3. Product Benchmarking
    • 12.8.4. Recent Development
  • 12.9. Teva Pharmaceuticals Industries Ltd.
    • 12.9.1. Company Overview
    • 12.9.2. Financial Performance
    • 12.9.3. Product Benchmarking
    • 12.9.4. Recent Development
  • 12.10. Viatris, Inc.
    • 12.10.1. Company Overview
    • 12.10.2. Financial Performance
    • 12.10.3. Product Benchmarking
    • 12.10.4. Recent Development
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제